229 related articles for article (PubMed ID: 27032393)
1. SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer.
Companioni Nápoles O; Tsao AC; Sanz-Anquela JM; Sala N; Bonet C; Pardo ML; Ding L; Simo O; Saqui-Salces M; Blanco VP; Gonzalez CA; Merchant JL
J Gastroenterol; 2017 Jan; 52(1):39-49. PubMed ID: 27032393
[TBL] [Abstract][Full Text] [Related]
2. Regulation of apoptosis is impaired in atrophic gastritis associated with gastric cancer.
Rosania R; Varbanova M; Wex T; Langner C; Bornschein J; Giorgio F; Ierardi E; Malfertheiner P
BMC Gastroenterol; 2017 Jun; 17(1):84. PubMed ID: 28662697
[TBL] [Abstract][Full Text] [Related]
3. Gene expression study and pathway analysis of histological subtypes of intestinal metaplasia that progress to gastric cancer.
Companioni O; Sanz-Anquela JM; Pardo ML; Puigdecanet E; Nonell L; García N; Parra Blanco V; López C; Andreu V; Cuatrecasas M; Garmendia M; Gisbert JP; Gonzalez CA; Sala N
PLoS One; 2017; 12(4):e0176043. PubMed ID: 28441455
[TBL] [Abstract][Full Text] [Related]
4. The Transition from Gastric Intestinal Metaplasia to Gastric Cancer Involves
Gingold-Belfer R; Kessler-Icekson G; Morgenstern S; Rath-Wolfson L; Zemel R; Boltin D; Levi Z; Herman-Edelstein M
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069715
[TBL] [Abstract][Full Text] [Related]
5. Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer.
Xu J; Chen S; Liang J; Hao T; Wang H; Liu G; Jin X; Li H; Zhang J; Zhang C; He Y
Front Immunol; 2022; 13():922138. PubMed ID: 36090985
[TBL] [Abstract][Full Text] [Related]
6. Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample.
Sipponen P; Kekki M; Siurala M
Cancer; 1983 Sep; 52(6):1062-8. PubMed ID: 6883274
[TBL] [Abstract][Full Text] [Related]
7. Schlafen 4-expressing myeloid-derived suppressor cells are induced during murine gastric metaplasia.
Ding L; Hayes MM; Photenhauer A; Eaton KA; Li Q; Ocadiz-Ruiz R; Merchant JL
J Clin Invest; 2016 Aug; 126(8):2867-80. PubMed ID: 27427984
[TBL] [Abstract][Full Text] [Related]
8. The expression of protein inhibitor of activated signal transducers and activators of transcription 3 in the evolutionary process of gastric cancer.
Liu LM; Yan MG; Yang DH; Sun WW; Zhang JX
Eur J Intern Med; 2011 Oct; 22(5):e31-5. PubMed ID: 21925039
[TBL] [Abstract][Full Text] [Related]
9. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
Liu D; He Q; Liu C
J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
[TBL] [Abstract][Full Text] [Related]
10. Potential role of chromatin remodeling factor genes in atrophic gastritis/gastric cancer risk.
Bilgiç F; Gerçeker E; Boyacıoğlu SÖ; Kasap E; Demirci U; Yıldırım H; Baykan AR; Yüceyar H
Turk J Gastroenterol; 2018 Jul; 29(4):427-435. PubMed ID: 30249557
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
Liu KS; Wong IO; Leung WK
World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis.
Li GQ; He Q; Yang L; Wang SB; Yu DD; He YQ; Hu J; Pan YM; Wu Y
Cell Physiol Biochem; 2017; 44(3):1242-1250. PubMed ID: 29179204
[TBL] [Abstract][Full Text] [Related]
13. Incomplete intestinal metaplasia as an indicator for early detection of gastric carcinoma in the events of helicobacter pylori positive chronic atrophic gastritis.
Vukobrat-Bijedić Z; Radović S; Husić-Selimović A; Gornjaković S
Bosn J Basic Med Sci; 2006 Nov; 6(4):48-53. PubMed ID: 17177650
[TBL] [Abstract][Full Text] [Related]
14. Expression of TERT in precancerous gastric lesions compared to gastric cancer.
Duarte MC; Babeto E; Leite KR; Miyazaki K; Borim AA; Rahal P; Silva AE
Braz J Med Biol Res; 2011 Feb; 44(2):100-4. PubMed ID: 21180888
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing.
Park CH; Lee AR; Lee YR; Eun CS; Lee SK; Han DS
Helicobacter; 2019 Feb; 24(1):e12547. PubMed ID: 30440093
[TBL] [Abstract][Full Text] [Related]
16. CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric intestinal metaplasia.
Koulis A; Di Costanzo N; Mitchell C; Lade S; Goode D; Busuttil RA; Boussioutas A
BMC Gastroenterol; 2022 Apr; 22(1):197. PubMed ID: 35448971
[TBL] [Abstract][Full Text] [Related]
17. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran.
Mansour-Ghanaei F; Joukar F; Soati F; Mansour-Ghanaei A; Atrkar-Roushan Z
Asian Pac J Cancer Prev; 2013; 14(6):3549-54. PubMed ID: 23886143
[TBL] [Abstract][Full Text] [Related]
18. Pseudopyloric Metaplasia Is Not Associated With the Development of Gastric Cancer.
Dilaghi E; Baldaro F; Pilozzi E; Conti L; Palumbo A; Esposito G; Annibale B; Lahner E
Am J Gastroenterol; 2021 Sep; 116(9):1859-1867. PubMed ID: 34313623
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratin expression patterns in noncardia, intestinal metaplasia-associated gastric adenocarcinoma: implication for the evaluation of intestinal metaplasia and tumors at the esophagogastric junction.
Shen B; Ormsby AH; Shen C; Dumot JA; Shao YW; Bevins CL; Gramlich TL
Cancer; 2002 Feb; 94(3):820-31. PubMed ID: 11857318
[TBL] [Abstract][Full Text] [Related]
20. DNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia.
Krishnan V; Lim DXE; Hoang PM; Srivastava S; Matsuo J; Huang KK; Zhu F; Ho KY; So JBY; Khor C; Tsao S; Teh M; Fock KM; Ang TL; Jeyasekharan AD; Tan P; Yeoh KG; Ito Y
Gut; 2020 Oct; 69(10):1738-1749. PubMed ID: 31937549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
